Madagascar Herbal Drug Consists of Prevention, Treatment Varieties- FG

0
615

The Federal Ministry of Health has revealed some components of the Madagascan herbal formulation, COVID-Organics, saying it contains two varieties of prevention and treatment for the infection.

The federal institution stated that samples of the drug have been sent to three agencies of the National Agency for Food and Drug Administration Control (NAFDAC); National Institute for Pharmaceutical Research and Development (NIPRD), and Nigerian Institute of Medical Research (NIMR) for thorough evaluation.

Madagascar Herbal Drug Consists of Prevention, Treatment Varieties- FG
Dr Osagie Ehanire

The FMoH disclosed through series of tweets on Twitter thus:”We have received Madagascar herbs and have found it to consist of 2 varieties; one labelled for prevention and the other for treatment. Samples have been sent to 3 of our agencies & @FmstNg for scientific evaluation.

“These are normal processes for new preparations to be approved for use in Nigeria, including clinical trials, toxicological & efficacy tests.

“Nigeria government will investigate all genuine efforts to find home grown solutions to the pandemic”, it stressed.

It said the herbal solution will be thoroughly x-rayed and analysed by the agencies to determine the constituents, toxicological, and efficacy.

The Minister of Health, Dr Osagie Ehanire, during the Presidential Task Force briefing on Thursday,  said: “Global efforts to find a cure for COVID-19, in which Nigeria is participating in the WHO solidarity trial, will be reviewed by our panel of experts, as WHO suspended the trial, due to alarm raised by a medical journal, on the safety of some drugs being tried, like hydroxychloroquine, chloroquine and their combinations”.

Director General of the West Africa Health Organization (WAHO), Prof. Stanley Okoli, also added that it will support traditional practitioners with claims of either an outright cure for COVID-19 or its treatment, with clinical trials.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments